Vertex Pharmaceuticals Reaches $558.88, a Fresh 52-Week Peak
As seen on the 24/7 Wall St. homepage on October 30, 2026.
Vertex Pharmaceuticals closed at $558.88, a fresh 52-week high and 0.16% above the September 3 peak. The $141.7 billion biotech has now reclaimed the top of its range after a two-month stretch spent trading closer to $500.
Continue ReadingShow less
Vertex Pharmaceuticals closed at $558.88 on October 30, clearing the prior 52-week high set on September 3. That margin confirms the earlier peak was not a ceiling, and momentum has carried the stock into new territory.
The move caps a recovery from levels closer to $500, where the stock spent much of a two-month consolidation phase. Breaking out of that range on a closing basis carries weight with investors who treat closing prices as the definitive verdict.
Sponsored
The company's market value stands at $141.7 billion, a scale that places Vertex among the largest biotechs in the world. Reaching a 52-week high at that size points to broad institutional participation.
The prior high from September 3 now becomes the key support level to watch. Holding above that earlier peak on any pullback reinforces the breakout.
Sources
Mentioned: VRTX